572 filings
Page 5 of 29
6-K
zs65g1w ly7a
18 Feb 21
Current report (foreign)
4:05pm
6-K
3o0rou23vqdsp
2 Feb 21
Current report (foreign)
7:40am
6-K
22li0cf9r7r3jd50f
28 Jan 21
Aeterna Zentaris Expands Orphan Drug Development Pipeline with Targeted Immunosuppressive Therapeutics
4:05pm
6-K
jaqtm4tza98y
26 Jan 21
Aeterna Zentaris Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
5:30pm
6-K
rkv0yr55nvlyrmqz6p7
7 Dec 20
Current report (foreign)
8:15am
6-K
8f6e8z35
16 Nov 20
Current report (foreign)
8:15am
6-K
5ll1hjg rbty05
5 Nov 20
Condensed Interim Consolidated Financial Statements
4:32pm
6-K
6yhux8myu7 hrrv
7 Oct 20
Current report (foreign)
9:11am
6-K
umue7x60z4b5g5kcr
5 Aug 20
Condensed Interim Consolidated Financial Statements
9:02pm
6-K
733j5jt7swjhzbs20ji
5 Aug 20
Current report (foreign)
9:22am
6-K
dju3zf
4 Aug 20
Aeterna Zentaris Announces $7.0 Million Registered Direct Offering priced at-the-market
12:00am
6-K
q2owca6lhvpi
31 Jul 20
Aeterna Zentaris Announces Continued Expansion of Intellectual Property Portfolio for Macimorelin with Additional Patent Applications
8:51am
6-K
levb vkaya
31 Jul 20
Current report (foreign)
12:00am
6-K
b5zi0w9yu
29 Jul 20
Aeterna Zentaris Receives Nasdaq Notification Regarding Minimum Bid Price Compliance; No Immediate Impact on Listing
7:10am
6-K
1hswegyvhaamdlpz4 k0
6 Jul 20
AETERNA zentaris announces pricing of $12 mIllion public offering
7:00am
6-K
owv1pe
25 Jun 20
AETERNAzentaris ANNOUNCES DISTRIBUTION AGREEMENT
8:05am
6-K
1771r
8 Jun 20
Current report (foreign)
8:30am
6-K
d65egl
4 Jun 20
AETERNAzentaris Receives EXTENSION FROM Nasdaq TO SATISFY CONTINUING listing REQUIREMENTS
4:49pm
6-K
el90chphp1npdt
18 May 20
Aeterna Zentaris announces Results of 2020 annual meeting of shareholders
12:00am
6-K/A
8hi8c
11 May 20
Condensed Interim Consolidated Financial Statements
10:51am